Colon & Rectal Carcinoma Market Competitors Profiles: Amgen, Roche, Merck, Pfizer, Bayer Healthcare, Spectrum, Novartis
Colorectal cancer (CRC) is one of the "big four" tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together.
View full press release